← Return to Genetic testing to determine drug suitability
DiscussionGenetic testing to determine drug suitability
Polymyalgia Rheumatica (PMR) | Last Active: Mar 16, 2024 | Replies (11)Comment receiving replies
Replies to "I discovered today that Sonic Laboratories (one of Australia's largest pathology labs) can reliably screen for..."
A genetic marker to inform my response to Leflunomide is too late for me. I have already tried and failed Leflunomide. However, Prednisone probably contributed to the failure. Leflunomide was discontinued due to infections. My rheumatologist said Prednisone and Leflunomide together caused too much immunosuppression. Otherwise, Leflunomide was working.